UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 28, 2022

Accession Number:	0001193125-22-061620
Submission Type:	POS AM
CIK: 0001517022 Company Name: Akebia Therapeutics, Inc. File Number: 333-253539